• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding

    The Baseline

    12
    Following
    368
    Stocks Tracked
    49
    Sectors & Interests
    Follow
    Load latest
    logo
    The Baseline
    08 Sep 2023
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. NMDC: 

    This iron ore producer rose by 15.9% in the past week and hit its 52-week high of Rs 145.6 on Friday. The spike follows the announcement of a 37.5% YoY increase in its August 2023 production to 3.4 million tonnes (MT). Its sales has also improved by 25.1% YoY to 3.5 MT. In Q1FY24, NMDC reported a 14.6% YoY rise in net profit to Rs 1,652.2 crore, beating Trendlyne Forecaster’s estimate by 7.4%. Its revenue grew by 15.8% YoY.  

    In August, NMDC had to decrease the price of lump ore and fines by Rs 300 per tonne to Rs 4,650 per tonne and Rs 3,910 per tonne, respectively, due to pricing pressure. China’s iron ore prices also dropped by 29.4% YoY from April 2023 to July 2023. Chairman and Managing Director Amitava Mukherjee says, “Prices have bottomed out and are expected to go up.” He believes that the rising volumes will compensate for the loss of pricing leverage. 

    NMDC expects to clock higher production and sales on a YoY basis in Q2, and due to lingering inventory on its book, it also expects dispatches to surpass production. The management has guided iron ore production to be around 49 MT in FY24 and 50 MT in FY25. 

    The company has planned a capex of Rs 2,000 crore in FY24, with Rs 610 crore already incurred. It also plans to incur incremental capex to increase the total capacity to 100 MT. Achieving this would require an annual capex of Rs 5,000 crore. NMDC is also poised to start gold mining in Australia by next month, subject to approval. 

    Sharekhan maintains a ‘Buy’ call on NMDC on the back of strong domestic demand and rising volumes. The brokerage says these would be the key growth drivers over FY24-25. The company also appears in a screener for stocks with target price upgrades by brokers.

    2. Nazara Technologies

    This gaming & esports company has risen by 12.8% over the past week till Friday, as its board approved raising nearly Rs 510 crore through a preferential allotment of equity shares. 

    On September 4, the firm announced a plan to raise Rs 100 crore by issuing just over 14 lakh shares to Kamath Associates and NKSquared, at a share price of Rs 714. These two entities are represented by the co-founders of Zerodha, Nikhil and Nithin Kamath. Then on September 7, it announced that its board approved raising Rs 410 crore from SBI Mutual Fund by issuing 57.2 lakh shares, again  at a price of Rs 714 per share. The stock shows up in a screener for companies in the PE ‘Buy’ zone with high durability and rising momentum scores. 

    The management has stated that these funds will be utilised towards capital requirements and growth objectives, which will include acquisitions and investments in other companies. The fresh capital will largely be used for the company’s inorganic expansion plans. 

    The street seems to be largely optimistic about the firm’s prospects, despite a mixed performance in Q1FY24. Its revenue fell by 12.1% QoQ to Rs 254.4 crore due to a sharp drop in the gaming segment. However, its net profit rose by nearly 7.5X QoQ, led by a drop in web-server expenses. 

    ICICI Securities believes the company will recover from Q2FY24 onwards, driven by healthy growth in the esports and gaming segments, led by subscriber additions and price increases. According to Trendlyne’s Forecaster, the consensus recommendation on the stock from 10 analysts is ‘Buy’.

    3. Bharat Heavy Electricals

    This heavy electrical equipment manufacturer has risen by 19.8% over the past week till Friday, driven by expectations of healthy growth. This positive outlook comes on the back of a robust inflow of orders across segments such as transmission, power, defence and railways. On September 4, the company won an order to design and commission the electro-mechanical package for the 2,880 MW hydropower Dibang Multipurpose Project in Arunachal Pradesh. It won three major power projects in August, two from NTPC (one of them valued at Rs 2,241.9 crore) and another contract from Mahan Energen worth Rs 4,000 crore. 

    Along with the strong order inflows, BHEL’s diversification efforts are starting to bear fruit. In a consortium with Titagarh Wagons, it won a project worth Rs 24,000 crore to build, supply and maintain 80 Vande Bharat train sets by 2029 and service them for 35 years. The company’s share in the order is estimated at Rs 15,000 crore. It also expects defence order inflows to rise in the coming quarters.

    According to reports, orders from non-power sectors are expected to make up 30% of the firm’s order book by FY26. The stock also shows up in a screener for companies with improving cash flows and high durability scores. 

    Overall, BHEL seems to be well-positioned to capitalise on India’s growing energy needs and the Centre’s increased focus on railways, defence indigenisation, and infrastructure. According to Trendlyne’s Forecaster, the company’s annual revenue and net profit are projected to rise by 13.6% YoY and 50.7% YoY, respectively, in FY24. 

    4. Coal India

    This coal producer has risen by 22.6% over the past week till Friday, outperforming the Nifty 50 by 19.7%. This comes after it reported healthy production and sales figures in August. Over the past quarter, the company’s share price rose by 22.3%, outperforming the index by 16.5%. Due to the sharp rise in price, it features in a screener of stocks with strong momentum. 

    Coal India’s production increased by 13.2% YoY to 52.3 million tonnes (MT) in August. The company’s total coal supplies to all consuming sectors (which include the power, cement, and steel sectors) increased by 15.3% to 59 MT. Its supplies to the power sector (1.5 MT per day) also exceeded the committed quantity of 1.4 MT per day. 

    In addition to the healthy business update, a positive outlook from analysts helped the rise in share price. Analysts anticipate an increase in thermal coal demand in the future, as thermal power generation picks up to meet increasing power demand. In the coming months, power demand, which has been on the rise since July due to unseasonal rains, is expected to remain elevated.

    Following the company’s encouraging business update, ICICI Securities maintains its ‘Buy’ rating with an unchanged target price of Rs 285. The brokerage believes that its FY24E sales volume estimate of 741mt (up 6.5% YoY) will likely be achieved, as the company has already delivered 7.5% YoY growth in offtake YTD in August. 

    5. Persistent Systems: 

    This IT consulting & software company has risen by 22.3% in the past month, driven by its initiatives in the Generative AI segment. The firmannounced a partnership with Google Cloud to launch the Generative AI suite. This partnership is expected to enhance Persistent Systems' capabilities in data modernization and facilitate the expansion of its business operations for clients. It has also joined  hands with Amazon Web Services (Code Whisperer) to train more than 16,000 employees in developing AI technology for clients. Persistent Systems expects the AI segment to contribute significantly to the revenue stream in the next three quarters.  

    The firm's Q1FY24 revenue improved by 23.6% YoY to Rs 2,321 crore on the back of strong deal wins and growth in the Hi-Tech (product engineering) segment. However, healthcare clients are cutting down on discretionary spending. The firm currently has a total contract value (TCV) of $380 million and an annual contract value (ACV) of $272 million. The stock shows up in a screener for companies with net profits increasing sequentially for the past four quarters.

    The firm’s EBIT margin has declined by 162 bps YoY to 16.13% due to higher H1-B visa filing costs and wage hikes. Meanwhile, its attrition rates dropped to a two-year low of 15.5%, while the utilisation rate increased by 103 bps QoQ to 78.3%. The firm plans to add another 800 employees in the next two quarters. During the recent quarter, the company opened four new offices in Tier 1 cities like Ahmedabad, Gurugram, Jaipur and Noida.

    The management has given a revenue guidance of 4% QoQ growth. However, the expected wage hike in Q2FY24 is likely to impact margins by 200 bps, which will be partly offset by higher utilisation, improvement in the offshore-onshore mix and a lower attrition rate.

    According to KR Choksey, the company’s book-to-bill ratio of 1.3 and its healthy order wins provide good visibility for revenue growth. The company's diversification into new verticals like cyber security, artificial intelligence, and consumer technology will also help revenue growth. The brokerage maintains a ‘Buy’ rating on the firm.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    07 Sep 2023
    Oil Marketing Companies stay undervalued despite record profits

    Oil Marketing Companies stay undervalued despite record profits

    By Shreesh Biradar

    Oil, the lifeblood of modern economies, is especially closely watched in India, where its impact on consumers can make or break elections. The Indian government has strategically invested in three oil marketing companies (OMCs) - Indian Oil (51.5% stake), Hindustan Petroleum(54.9% via ONGC) and Bharat Petroleum (53% stake). Together, these Big Three control nearly 80% of the domestic retail market.

    After the spike in oil prices in 2022, India began buying cheap crude from Russia, providing the OMCs with higher gross refining margins (GRMs). These impressive margins however have been limited by lower prices at the domestic retail level. 

    The government’s back-and-forth on prices at the pump has put a ceiling on how much profit OMCs can make. It has caused a tricky balance between happy Indian consumers and the financial viability of India's oil marketing companies. 

    Although the OMCs (Hindustan Petroleum, Indian Oil and Bharat Petroleum) reported record profits of Rs 30,500 crore in Q1FY24, their stock prices haven't moved much. With consumption slowing down in Europe and crude prices rising, the margins of these companies have fallen. With elections coming up and Saudi Arabia extending oil production cuts until December, government intervention can further impact the profitability of OMCs. 

    In this week’s Analyticks:

    • Oil Marketing Companies: OMCs stay undervalued despite record profits
    • Screener: Oil & Gas stocks trading at lower PE than their industry average

    Let it flow: India gets ready for post-monsoon surge in oil demand 

    Oil consumption in India usually takes a dip during the monsoon season, as rain disrupts transportation and mining activities. Over the past three quarters, India’s fuel consumption has flatlined at 57 million tonnes. Although the consumption in July increased by 1.9% YoY, it was still a month on month decline of 6.6%. The highest drop was in diesel consumption, which decreased by 13% MoM. 

    India’s fuel consumption flatlines over three consecutivequarters

    However, India’s fuel consumption should rise again after a weak start in Q1FY24. According to S&P, India’s oil demand in 2023 is expected to increase by 7% from 2019 levels. This figure surpasses earlier estimates, which pegged the demand growth at 6%.

    Marketing margins improve, but it's a rocky road ahead 

    FY23 was a tough year for OMCs. The freeze in retail fuel prices since April 2022 compelled OMCs to bear a blended loss of  Rs 3.4/litre (with a profit of Rs 2.3/litre on petrol and a loss of Rs 5.9/litre on diesel).

    However, as crude prices dropped from $82/barrel to $72/barrel in Q4FY23, OMCs’ marketing margins turned positive.  With crude prices consistently below $75 in Q1FY24, OMCs managed to make a blended profit of Rs 11.9/litre.

    Diesel retail margins surge to nine-quarter high in Q1FY24 

    The upswing in crude oil prices during July and August 2023 has once again impacted marketing margins for OMCs. As of August 2023, their margins stand at a profit of Rs 5.5/litre for petrol, and a loss of Rs 0.7/litre for diesel. Considering the approaching election, OMCs may also face pricing pressures from the government in the coming months.

    Brent crude prices rise in Q2FY24

    If oil prices climb above the $85 mark and stay there, OMCs could find themselves back in the red. Even if oil prices hover around $80-85, the government may ask the OMCs to reduce fuel retailing prices, denting their profitability. As an initial step ahead of elections, the government is already planning to cut excise duty on retail fuel to ease inflation.

    Gross refining margins go lower

    The strategic move by OMCs to import cheaper Russian Ural and export refined oil at higher prices to Europe helped expand gross refining margins (GRMs).  In Q1FY23, GRMs surged thanks to leftover low-cost inventory, as crude prices rose above $100 per barrel. However, GRMs of the three OMCs declined in Q1FY24 from their peak levels in Q4FY23. The average GRM, which stood at $16.6/barrel in Q4FY23, fell to $9.43/barrel in Q1FY24.

    OMCs’ gross refining margins contract in Q1FY24

    The decline in GRM was due to the increasing prices of Russian Ural and reduced demand from Europe. Considering the sharp recovery in Singapore GRMs post-July 2023 to around $12.1/barrel, Indian OMCs’ GRMs are expected to increase in Q2FY24. However, the government increased the windfall tax on diesel exports from Rs 1/litre to Rs 5.5/litre starting from August 2023.

    Singapore's gross refining margins are lower than Indian refineries

    Refining margins are projected to drop from their peak in Q1FY24. As oil prices stabilise, GRMs are predicted to decline to around $8-9 for FY24 overall. 

    Investors and government to bear the brunt

    The daily revision of fuel prices has been frozen since April 2022. This policy shift has led to huge losses for fuel retailers. To compensate for the loss, the government announced a Rs 30,000 crore equity infusion in the 2023 budget.

    In line with that, IOCL and BPCL have both announced rights issues, while HPCL is expected to issue preference shares to the government. The rights issue of IOCL and BPCL is expected to draw capital of Rs 11,330 crore and Rs 9,500 crore, respectively, from the government. A similar amount is expected to be subscribed by investors, as the government holds substantial stake in both firms. 

    Even though the money raised through rights/preferential issues is for the OMCs’ capex plans, it is also compensation for the losses these companies incurred in FY23.

    Investors are, no surprise, sceptical despite OMC profits

    In 2018, India’s then Minister for Petroleum and Natural Gas, Dharmendra Pradhan, said that “the government has no business in interfering in the pricing mechanism of petroleum products, which should be left to the oil companies to decide on a daily basis”.

    Fast forward to 2022 - when oil prices surged above $85, the government abandoned that policy fast, and OMCs froze retail prices, taking a hit to their profitability. Interestingly, the government denied any intervention and put the blame on OMCs. India’s current Minister for Petroleum and Natural Gas, Hardeep Singh Puri, said that “OMCs acted as good corporate citizens and insulated the economy and citizens from increase in energy prices”. 

    The problem faced by government-owned OMCs is that these listed firms, while designed to make profits, have begun to resemble charitable institutions, incurring losses as needed to protect the general public.

    While the general public and economy approve of this, investors have largely steered clear of these stocks. Increased scepticism around government intervention has led to these stocks making negative returns over the past three months, despite record profits. And for now, with Saudi Arabia hinting at more production cuts in the coming months, that is unlikely to change.


    Screener: Oil & gas stocks trading at a lower PE than their Industry average

    Oil & Gas Valuation Leaders: Refineries and petro-products industry takes lead in valuation 

    The oil refinery industry is currently seeing some of the highest valuations in the oil & gas sector.  This advantage comes from the availability of cheap oil from Russia and higher price realizations on refined oil exports to Europe. However, domestic retail prices have been frozen, causing losses in marketing and distribution. This screener shows stocks from the oil & gas sector that have been trading below the industry average PE. 

    Significant stocks that appear in the screener are Petronet LNG, Indian Oil Corporation, Mangalore Refinery and Petrochemicals, Hindustan Petroleum Corporation, Oil India, Bharat Petroleum Corporation and Chennai Petroleum Corporation.

    Petronet LNG’s revenue declined by 18.3% YoY to Rs 1.2 lakh crore in Q1FY24, while its net profit increased by 12.7% YoY to Rs 7,899 crore compared to Rs 6,142 crore in Q4FY23. This oil marketing and distribution company’s EBITDA margins expanded by Rs 4 per metric million British thermal units (mmbtu) YoY and by Rs 8 per mmbtu QoQ. The margin expansion was led by softer LNG prices.

    Hindustan Petroleum Corp’s revenue grew by 10.3% QoQ to Rs 1.2 lakh crore in Q1FY24. Its net profit also improved by 87.5% QoQ to Rs 6,765.5 crore, compared to a loss in Q1FY23. This oil & gas company achieved an operating profit margin of 8.1% during the quarter. This was aided by a decline in the cost of raw materials due to an 8.7% decrease in Brent crude oil prices to $72.7 per barrel.

    Oil India’s revenue declined by 24% YoY to Rs 45,312 crore in Q1FY24, while its net profit increased by 3.7% YoY. This oil exploration and production company’s decrease in revenue was on account of lower price realizations for crude oil ($76.9/barrel in Q1FY24 vs. $112.7 in Q1FY23). However, its EBITDA margin expanded by 780 bps YoY on the back of a reduction in well write-offs, a decline in forex losses and a decrease in other provisions.

    You can find more screeners here.

    Signing off,

    The Trendlyne Team

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    05 Sep 2023
    Five analyst picks this week

    Five analyst picks this week

    By Abhiraj Panchal

    1. Thermax: 

    Sharekhan maintains its ‘Buy’ rating on this heavy electrical equipment manufacturer and raises the target price to Rs 3,235 from Rs 2,790. This implies an upside of 14.2%. The analysts believe that the firm is well-positioned to benefit from India’s transition to green energy, given its diverse product portfolio. They add, “Thermax’s focus on launching innovative products in all its segments supports its long-term growth.” They expect the order inflow to be dominated by steel, oil & gas and petrochemicals in the near term.

    The analysts expect the firm’s margins to improve in the coming quarters as commodity prices are declining. Along with a healthy orderbook, they foresee the firm’s robust balance sheet, strong cash flows, and low working capital to drive growth. They project the company’s revenue to grow at a CAGR of 15% over FY23-26.  

    2. Reliance Industries: 

    Bob Capital Markets keeps its ‘Buy’ rating on this refineries giant with a target price of Rs 3,015. This implies an upside of 19.8%. Analysts Kirtan Mehta and Yash Thakur remain optimistic about the firm’s growth prospects due to its focus on consumption and technology-driven growth. They add, “The company is also looking to tap global growth potential with its digital and FMCG businesses.”

    Mehta and Thakur also find the company’s strategy of embracing new technologies like 5G, and integrating its retail arm with the e-commerce platform, JioMart, as key positives. They expect the rollout of the 5G network to boost market share and average revenue per user (ARPU) for Jio. The analysts believe that the firm is equipped for “robust long-term growth” and anticipates its net profit to grow at a CAGR of 12.1% over FY23-25.  

    3. Mahanagar Gas: 

    Geojit BNP Paribas maintains its 'Buy' rating on this non-electrical utilities company with a target price of Rs 1,224, indicating an upside of 18.6%. Cyril Charly at Geojit BNP Paribas is positive about the company’s expanding profit margins, due to lower input costs and increased price realizations in the compressed natural gas business.

    Charly is upbeat as the government has approved the Parikh Committee's recommendation to cap the cost of domestic gas at USD 6.5/mmBtu, leading to decreased gas expenses. Its EBITDA has surged by an impressive 82.5% YoY, primarily due to reduced natural gas procurement costs. He expects this positive momentum to continue, as the cap on input costs is projected to remain in effect for the medium term.

    The acquisition of Unison Enviro is also a strategic move that enables expansion into regions like Ratnagiri and Karnataka. The investment in distribution infrastructure, strategic acquisitions, and the government's commitment to increasing the share of sustainable energy is expected to drive volume growth for the company.

    4. SKF India: 

    ICICI Direct maintains its ‘Buy’ call on this ball and roller bearings manufacturer company with a target price of Rs 6,400, indicating an upside of 22.1%. Analysts Chirag Shah and Vijay Goel say, “SKF India is well placed to ride the strong demand cycle in the domestic bearings market, led by its focus on high-growth sectors, new product developments and increasing localisation of products.” 

    The analysts are optimistic about SKF India’s rich experience in the design, development and manufacturing of bearings, seals and lubrication systems. They also believe that it is well positioned with a wide range of products & services. The company is also focusing on growth in segments like electric vehicles, renewable energy, railways and mining. 

    Shah and Goel expect SKF India’s operational and financial performance to improve considerably and estimate revenue and PAT to grow at 15% and 22.8% CAGR respectively over FY24-25. 

    5. Coal India: 

    ICICI Securities maintains a 'Buy' rating on this coal-mining company, with a target price of Rs 285, indicating an upside of 14.6%. Analysts Amit Dixit, Mohit Lohia, and Pritish Urumkar hold an optimistic outlook due to the company's consistent outperformance in production and sales volume, which has extended into the fifth consecutive month in FY24.

    According to ICICI Securities analysts, the company's earnings are highly sensitive to volumes. Its year-to-date performance suggests an upswing in volume for both regulated and non-regulated customers. This trend is expected to lead to improved operating leverage and higher fuel supply agreement prices.

    The analysts note that the pithead inventory, currently at 45.3 million metric tonnes, remains comfortably positioned due to production ramp-up. They foresee that the company will benefit from operating leverage due to increased sales volumes, in both non-regulated sector and e-auction customers. This is despite a slight decrease in premiums compared to FY23. However, Dixit, Lohia and Urumkar also project a progressive rise in e-auction bookings at higher prices due to the 20-25% surge in international coal prices in July 2023. 

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    2
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    01 Sep 2023
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. Coforge

    Thissoftware and services company has been in thenews as its promoter, Baring PE, sold its entire stake of 26.6% through block deals on August 24. The stock gained 9.7% on the day of sale. The complete stake sale by promoters removes the impact of the periodic bulk deal sales by the promoter, which had limited the upside for the stock, despite the firm’s consistent performance. 

    According toTrendlyne Technicals, the stock has gained 15.9% in the past month, supported by its strong Q1FY24 results. The firm reported a 2.7% QoQ increase in revenue and a 44% rise in net profit during the quarter. The BFSI segment was the major revenue driver, with a QoQ growth of 4%.

    Coforge reported its highest-ever deal wins of $531 million in Q1FY24. Its average deal win in the past four quarters stands at $370 million. This has resulted in a 12-month executable order book of $897 million. Coforge has also reported a net addition of 1,482 employees in the trailing 12 months, a positive trend in contrast to the decline observed in its peers’ employee counts. Another strength lies in Coforge’s attrition rate, which is one of the lowest in the industry at 13.3% in Q1FY24.

    The management has provided a revenue guidance of 13%-16% for FY24, with a gross margin expansion of around 50 bps. The revenue growth will be backed by the huge order book, while margin expansion will be aided by moderation in onsite expenses, wage hikes, and a lower attrition rate.

    America makes up over half of the company’s Q1 revenue. The growth from this region has improved by 5.8% QoQ. However, top-line growth was impacted by EMEA (Europe, Middle East, Africa) and ROW (rest of world), which have grown by only 1%.

    Sharekhan says that the complete stake sale by promoters removes the oversupply of shares and doesn’t limit the upside. Also, the deal wins in the quarter provide visibility for revenue growth. The brokerage maintains its ‘Buy’ rating on the stock.

    2. Finolex Industries

    This pipe manufacturer hit an all-time high of Rs 250 today, a 24.2% increase in the past month following its Q1FY24 results. The company’s profit has surged by 16.2% YoY to Rs 115.3 crore, beating Trendlyne Forecaster's estimate by 5.6%. Its revenue also grew marginally and features in a screener for stocks with increasing revenue for the past three quarters.

    The company’s pipe volume has grown by 28.1% YoY, driven by seasonally strong demand from the agriculture sector, and momentum from the plumbing segment. The overall pipe manufacturing sector saw increased volumes, with competitors like Astral and Apollo Pipes reporting volume growth of 31.1% YoY and 47% YoY, respectively.

    EBITDA margin contracted by 612 bps sequentially due to the impact on profitability in the PVC (polyvinyl chloride) resin segment. This was the result of a 40.4% YoY drop in PVC resin price, which led to a lower selling price of existing inventory. Finolex’s management has guided for a 15% CAGR in pipe volume over the next five years. The company has also planned a capex of Rs 200 crore and 250 crore for FY24 and FY25, respectively, mostly for mold additions in pipe and fittings, and maintenance. 

    As of Q1FY24, the company has a net cash surplus of Rs 1,650 crore. According to Chief Financial Officer Niraj Kedia, “The surplus cash will be used for expansion, or paid out as dividend or buyback if there are no proper investment avenues.”

    ICICI Securities maintains a ‘Buy’ call on Finolex Industries on the back of margin expansion due to lower raw material prices in both agriculture and non-agriculture segments.

    3. BSE

    This banking & finance stock has surged by more than 5% for three consecutive sessions to touch an all-time high of Rs 1,138.8 per share. The boost came as its derivatives market share increased to 3.4% in August from 0% in April. Its expiry day market share also jumped to 11%. According to Trendlyne’s Technicals, the stock has risen by 31.3% over the past month, helping it to appear in a screener of stocks that have gained more than 20% in the same period.

    In addition, rumours have surfaced regarding a potential merger of the exchange with the commodity exchange MCX. This is driven by MCX’s need for  technology-related solutions for its trading platform and BSE’s potential to strengthen its position through MCX’s commodity volumes. The silence from the exchanges regarding these rumours has caused many to take the possibility seriously. 

    HDFC Securities has upgraded the stock to a ‘Buy’ rating from ‘Accumulate’, with an increased target price of Rs 1,230 per share. This indicates a potential upside of 9.2%. The brokerage believes that the BSE derivatives will grow on the back of onboarding of large member brokers, the launch of new weekly index contracts, hedging activity, and a continued increase in active traders. It expects the exchange’s revenue to grow at a CAGR of 13.1% over FY22-26, led by growth in transaction revenue.

    4. Indian Hotels Co

    This hotel chain rose by 7.9% between Wednesday and Friday, reaching a high on Wednesday, followed by new highs on both Thursday and Friday. This surge comes on the back of a healthy business outlook for the hotel industry. Given its expansive presence across India, Indian Hotels is expected to benefit from robust domestic demand and the recovery of inbound international travel to pre-covid levels. Puneet Chhatwal, the MD & CEO of Indian Hotels, says, “We continue to envelop India and are present in over 125 locations across 31 states and union territories.”

    Along with these industry tailwinds, events such as the ICC Men’s World Cup, G20 Summit, and the Miss World Beauty Contest being hosted in India are expected to boost travel. In Q1FY24, the company opened five new hotels and signed 11 new hotels (Managed Properties). The management’s plans include the opening of more than 20 hotels and a capex of more than Rs 600 crore in FY24. The company has managed to expand its network without taking on a lot of debt, and shows up in a screener for companies with improving cash flows from operations over the past two years.

    With demand continuing to outpace supply in the industry, branded hotel chains have been able to raise room rates. The company expects this favourable supply-demand balance to persist in the coming quarters, allowing it to increase room rates without sacrificing occupancy rates during the holiday season in H2FY24. Trendlyne’s Forecaster estimates the hotel chain’s annual revenue and profit to grow by 13.7% YoY and 22.6% YoY in FY24 respectively.

    5. Shoppers Stop

    This retailing company declined by over 12% in intraday trade on Monday following the exit of its Managing Director & CEO, Venugopal G Nair, effective from August 31, citing personal reasons. Having held the CEO position since November 2020, Nair’s tenure saw the company’s share price surge by over 300%. The company has appointed Kavindra Mishra, the CEO of Homestop, as the  Executive Director & CEO for a period of three years, effective from September 1, 2023.

    Under Venugopal’s leadership, the company implemented a growth plan focusing on four key aspects: private label, omnichannel, beauty business, and store expansion. In Q1FY24, Shoppers Stop introduced an affordable retail format called ‘Intune’. According to Nair, “Intune is a ‘Fashion For All’ format, which is one of our strategic initiatives to cater to young families.”

    Despite the company's assurance of maintaining the strategy developed during Venugopal’s tenure, its share price has fallen.The company also stated that it would continue to prioritize opening smaller-sized stores for enhanced efficiency and reiterated its plans to add 12-13 departmental stores for FY24. In Q1FY24, the company added six beauty stores, but the opening of the targeted 2-3 department stores was delayed.

    During the quarter, Shoppers Stop’s net profit declined by 36.4% to Rs 14.5 crore due to an increase in employee expenses, and depreciation & amortization costs. Meanwhile, its revenue grew by 4.9% to Rs 1,000.9 crore. According to Trendlyne’s Forecaster, the firm’s revenue is expected to increase by 12.3% in FY24.

    Post the announcement of the CEO's resignation, Motilal Oswal reiterates its ‘Neutral’ rating, with a target price of Rs 750. The brokerage believes that the company’s focus on growing its beauty segment, improving the private label mix, and opening smaller-sized stores along with steady store addition guidance, should aid revenues.

    Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.

    1
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener Example mcap screener
    01 Sep 2023

    Example mcap screener

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    31 Aug 2023
    US market comes back to life for Indian pharma | Screener: Outperforming pharma stocks

    US market comes back to life for Indian pharma | Screener: Outperforming pharma stocks

    By Tejas MD

    After hitting its all-time high of 19,991.9 on July 20, the Nifty 50 index missed the much-anticipated 20K level by a sneeze and reversed course. The benchmark is now set to post a monthly loss in August – for the first time since February this year. 

    High food inflation in July due to El Nino and a fear of contagion from the shadow banking crisis in China dampened investor sentiment in August. The 20,000 mark remains elusive so far for the Nifty. 

    The deathless zombie that is inflation also returned – it rose above the RBI’s upper tolerance limit of 6% in July. 

    Food prices had started rising in June, and accelerated in July as farmers across India were hit by unseasonal rains and heatwaves that destroyed several crops. The resulting unexpected rise in food inflation has made investors cautious. 

    But despite the Nifty falling in the past month, one industry that rose is Pharmaceuticals. In fact, this industry has outperformed the Nifty 50 over the past quarter and year. 

    The pharma sector’s rise accelerated after its Q1FY24 results, as these companies showed healthy revenue and profit growth thanks to a turnaround in the US generics market. This comes after a long period of weakness for Indian drug makers. Is the pharma sector set to continue outperforming in the coming months? Let’s find out.

    In this week’s Analyticks, 

    • Mood shift: US market back on pharma companies’ radar as pricing pressures ease
    • Screener: Pharma stocks rising more than 5% over the past month, with YoY growth in net profit and revenue, and operating margin growth

    A tough time for Indian pharma in the US may finally end

    Domestic pharma companies were the pandemic stars of 2020, but their lights dimmed in 2021 and 2022. The Nifty Pharma underperformed the benchmark Nifty 50 index by 14% and 15.5% in 2021 and 2022 respectively. The US generics market, which had been a cash cow for Indian pharma in the past decade, failed to deliver after the US regulator encouraged more competition in this space. The resulting pressure on prices hit profitability hard. 

    But the prolonged period of intense competition in the US saw many losers. On Cipla’s Q1FY24 earnings call, Umang Vohra, Managing Director and Global CEO said, “A large number of US companies are either amalgamating, merging, or going bankrupt. That is eliminating a number of players in the system.”

    The pricing pressure has as a result, eased in the past two quarters and the management of all major Indian companies see a better outlook in US generics for FY24. 

    Better supply, new launches and lower raw material costs are also driving the generics segment’s rebound.  

    The two tough years for Indian pharma saw them improvising more. Drug makers like Sun Pharma, Cipla and Zydus Lifesciences diversified their product mix into complex generics, specialty drugs, peptides and injectables, where the pricing pressure was lower.

    Now with the generics segment also recovering, pharma companies are reaping benefits from their efforts in higher-margin complex generics as well as the generics segment.  

    Pharma companies outperform the Nifty 50 over the past quarter and six months

    US pharma market outperforms Indian market in FY23

    Revenue from the US generics market for top pharma companies rose 16% YoY in FY23 and outperformed the domestic market’s growth by a big margin. 

    US generics market turns around while the Indian market growth moderates

    Top pharma companies’ US business rose sharply in Q1FY24 while Indian business growth moderated.

    US and International businesses drive Indian pharma companies’ revenue in Q1FY24

    New product launches with drug exclusivity like Revlimid helped grow profit margins in the past two quarters. Companies are focussing on multiple new launches, as margins here are higher before competitors launch alternatives.

    To launch a new product in the US, companies need approval from the US Food and Drug Administration (USFDA) via the abbreviated new drug application (ANDA). India’s share in ANDA approvals was at 49% (a record high) of all ANDAs approved in FY23.

    Indian drug makers’ ANDA approval share bounces back after a dip in 2021


    Falling raw material and freight costs help margins recover

    In 2021 and 2022, raw material and freight costs were at an all-time high for pharma companies. But in 2023, raw material and freight costs are on a downtrend. 

    Input prices fall YoY after reaching all-time highs in 2022

    Input prices of major raw materials like para amino phenol and antibiotics have fallen over the past year and helped pharma companies’ margins rise QoQ and YoY in Q1FY24. 

    New product launches and falling input prices help margins rise in Q1

    However, active pharmaceutical ingredient (API) manufacturers like Divi's Laboratories are still facing margin pressure, as these companies import a higher percentage of their inputs (key starting materials) from China, which has pricing power. 

    China’s share in India’s key starting materials import rises in FY23

    API manufacturers also have to compete with China in exports. If China's API exports ramp up, these bulk drug manufacturers’ margin pressures could persist through the year. 

    Revenue visibility is high, but growth opportunities are murky

    The Indian pharma market (IPM) is expected to grow at a steady CAGR of 8-10% over the next five years. Key factors that drive the IPM are volume growth, price hikes and new product launches. The main reason for IPM growth moderating in FY23 is the slower volume growth.

    Indian pharma industry grows 9.3% in FY23 led by price hikes

    Pharma companies have tried to offset this with price hikes, but they don’t have complete pricing power. The National Pharmaceutical Pricing Authority sets ceiling prices for several essential drugs that are part of the National List of Essential Medicines (NLEMs).

    These ceiling prices are revised in line with changes in the wholesale price index (WPI) to factor in inflation on a YoY basis. 

    Number of drugs covered under NLEM is on a steady rise

    For non-NLEM products, Indian pharma companies can increase prices by up to 10% every year.

    The magic pill for pharma: a diversified product and geo mix

    Banking on just US business growth could be risky for Indian pharma companies, as USFDA regulations and inspections can play spoilsport. For example, Cipla’s share fell over 7% after its Pithampur unit got eight observations from the USFDA in February. This issue is yet to be resolved. This is where a diversified product and geo mix comes into play to reduce risks. 

    Like any other industry, pharma goes through different cycles as business dynamics change. In a Crisil discussion, Lakhshay Kataria, CFO of J B Chemicals & Pharmaceuticals said, “Two years ago we were apprehensive about the US and international market, but now the US market looks lucrative. So, diversification is key and companies with varied product and geo mixes can ride the winds of change in different geos, and grow at a faster rate”.


    Screener: Pharma stocks that are rising over 5% in the past month, with net profit and margin growth

     Natco Pharma’s revenue growth is among the highest in the pharma sector

    This week, we take a look at pharma stocks that have performed better than the sector in Q1FY24. This screener shows pharma stocks which have risen more than 5% in share price with growth in Q1FY24 revenues, net profit and operating profit margin. 

    Major stocks in the screener are Caplin Point Laboratories, JB Chemicals & Pharmaceuticals, Lupin, Natco Pharma and Ajanta Pharma.

    Caplin Point Laboratories rose 20.9% over the past month, the highest among the pharma stocks. It rose on the back of a 14.2% YoY growth in its revenue in Q1FY24, aided by improved sales in the semi-regulated markets of Latin America and Africa which contributed to 86% of its revenue. The company’s net profit increased by 21.7% YoY, which helped in expanding its operating profit margin.

    Natco Pharma gained 8.2% over the past month owing to a 28.9% YoY growth in its revenue in Q1FY24, the highest in the pharma sector. Improvement in sales from gRevlimid, domestic and agrochemicals businesses helped revenues improve. Its net profit grew by 31.2% YoY thanks to a reduction in employee benefit expenses.

    Lupin has risen 12.7% over the past month due to a 28.6% YoY growth in its revenue in Q1FY24. Improvement in sales from North America, India and active pharmaceutical ingredient (API) businesses led to topline growth. The company also posted a net profit of Rs 452.3 crore in Q1FY24 compared to a loss in Q1FY23. 

    You can find more screeners here.

    Signing off,

    The Trendlyne Team

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    30 Aug 2023
    Five analyst picks this week

    Five analyst picks this week

    By Suhas Reddy

    1. Pidilite Industries:

    Geojit BNP Paribas upgrades its rating on this adhesives manufacturer to ‘Buy’ from ‘Hold’ and raises the target price to Rs 2,792 from Rs 2,726. This implies an upside of 8.4%. In Q1FY24, the company’s net profit rose 32.4% YoY to Rs 468.2 crore and revenue grew by 5.6% YoY. Analyst Anil R says, “Performance in Q1FY24 was driven by volume growth in domestic Consumer & Bazaar (C&B) business segments.” He also points out that a reduction in raw material prices along with operational efficiencies aided healthy growth in net profit. 

    The firm’s management expects deeper expansion into rural areas, uptick in construction activity and a good monsoon to push growth in the near term. Also, the company sees exports rising in Q2FY24 and Q3FY24. 

    In light of Pidilite’s healthy Q1 performance and the recent correction in the stock price, Anil R believes the firm is trading at an attractive valuation, thus the upgrade in recommendation and target price. He expects the company’s net profit to grow at a CAGR of 30% over FY23-25.

    2. 3M India:

    ICICI Securities maintains its 'Buy' rating on this industrial machinery company with a target price of Rs 35,200, implying an upside potential of 11.5%. Analysts Aniruddha Joshi, Karan Bhuwania, and Nilesh Patil have a positive outlook, given the growth of 3M’s end-user industries such as automotive, infrastructure, and manufacturing. These factors bode well for 3M India.

    The analysts highlight the company's pricing power, successfully transferring added costs and boosting EBITDA margins to 15.3% in FY23 from 11.7% in FY22. They foresee growth through new products and strategic partnerships, coupled with expenditure reduction in ad spend and working capital, driving improved FY23 margins.

    Additionally, the analysts are of the opinion that the company boasts robust brand value and stands to gain from its well-established distribution network. They also factor in 3M India's global relationships with major manufacturers. They believe that 3M India should benefit significantly from its access to the technological resources of its parent company.

    3. Mahindra & Mahindra:

    Sharekhan maintains its buy call on this automobile manufacturer and raises its target price to Rs 1,736. This indicates an upside of 9.9%. Analysts from Sharekhan say, “Mahindra & Mahindra strategically aims to strengthen positioning in the overseas market with the introduction of global products.” 

    The analysts remain optimistic as the company introduced multiple concept vehicles to cater to domestic as well as international markets in the tractor, E-SUV, and pick-up vehicle segment. Mahindra launched the OJA platform in the lightweight tractor segment and Thar.e in the electric SUV segment. Even though historically the company’s operating performance was largely dependent on the tractor segment, the analysts now believe that the auto segment will drive its operating performance in the coming years due to increasing volumes going ahead. 

    The analysts maintain the call on the back of a robust order book in the private vehicle segment, market leadership in the tractor segment, opportunity to grow in farm machinery and its road map for the electric vehicles space.

    4. CIE Automotive India:

    ICICI Direct assigns a ‘Buy’ rating to this auto parts manufacturer with a target price of Rs 625, indicating an upside of 21.4%. The company’s management plans to incur a growth capex of approx 5% of its sales. At the same time, it plans on improving operational efficiencies in its European operations. 

    Given the new order wins in the electric vehicle (EV) domain accompanied by  the growing domestic market, cyclical upswing in commercial vehicle space, and steady demand for two-wheelers, the analyst Shashank Kanodia says, “CIE is well poised for double-digit revenue growth and a further improvement in margins.”

    The analyst believes that India is being looked at as a credible alternate manufacturing hub amid the China +1 trend, and so will be a focus for auto ancillaries. He also remains positive about the company as it is actively de-risking its existing business product profile by entering into EV products, which provide growth longevity. He assigns the call on the back of improving margins, return ratios and consistent healthy cash flow generation.

    5. Bajaj Auto:

    Axis Securities maintains a 'Buy' rating on this 2/3 wheeler company with a target price of Rs 5,400, indicating an upside of 15.8%. Analysts Aditya Welekar and Shridhar Kallani are optimistic about the company's future due to its focus on electric vehicles (EV) and premium motorcycles, which align with changing industry trends.

    Despite lower sales volumes in FY23, analysts at Axis Securities believe the company performed well. They attribute this success to higher average selling prices (ASPs) of their vehicles, driven by price hikes, increased domestic sales, and a larger share of the 125cc+ segment and three-wheeler sales.

    The analysts also highlight the company's strong brand value, citing its exclusive dealership networks for KTM and the recent launch of Triumph motorcycles. They consider the company's investment plans for FY24 as a significant growth driver, with Rs 1,000 crore allocated for expansion, which includes Rs 500 crore specifically for the EV segment.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    (You can find all analyst picks here)

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    29 Aug 2023

    Chart of the week: Top CEO salaries across major Indian sectors

    By Akshat Singh

    One thing CEOs cannot avoid is attention to their compensation packages. If you are in the C-suite of a listed company, your salary is inevitably going to be discussed and compared to your peers. There is danger on the upside (“Aren’t they getting too much?”) and on the downside (“Maybe they are not a great CEO.”) 

    But these salaries also showcase a company's values, their talent retention strategies, and dedication to fairness. Narayana Murthy, the founder of Infosys, was for example extremely against high salaries for the top management, saying that a CEO salary should not be more than 25X of the least paid employee. That rule, if we look at the top paid CEOs, has long been thrown out of the window. 

    CEO salaries are also potential red flags. For instance, a big YoY jump in CEO pay when the company’s revenue or net profit fell considerably in the same period raises corporate governance questions. 

    In this edition of Chart of the Week, we explore major market sectors to examine the highest CEO salaries from Trendlyne’s CEO salary dashboard, and compare them as a percentage of their companies' FY23 revenues.

    We begin our analysis with the most highly-paid sector, software and services. Thierry Delaporte, the Managing Director & CEO of Wipro, leads with an annual remuneration of Rs 82.4 crore in FY23. This is a 3.3% rise from his remuneration in FY22 as the company’s revenue grew by 14% YoY in FY23 while the net profit declined by 7.2% YoY. His earnings account for 0.1% of the company’s FY23 revenue. 

    In the same sector, Sandeep Kalra, the Executive Director & CEO of Persistent Systems, earns an annual salary of Rs 61.7 crore in FY23, a substantial 31.6% rise from FY22. This is 0.7% of the company’s FY23 revenue of Rs 8,421.2 crore. The company did very well during the IT slowdown, posting an increase in net profit by 33.4% YoY in FY23. 

    Coming in third is Nitin Rakesh, the Managing Director & CEO of Mphasis, who receives an annual remuneration of Rs 59.2 crore in FY23, equivalent to 0.4% of the company’s FY23 revenue of Rs 13,960.1 crore.

    Turning our attention to the banking and finance sector, Keki M Mistry, the Vice-Chairman & CEO of Housing Development Finance Corp, emerges as a prominent figure with an annual salary of Rs 20.8 crore in FY23. However, it's worth noting that HDFC is delisted due to the significant merger involving HDFC and HDFC Bank. As of August 2023, Keki Mistry is no longer CEO and is to be a ‘strategic advisor’ to all the financial ventures of Poonawalla Group. VP Nandakumar, the Managing Director & CEO of Manappuram Finance, receives an annual remuneration of Rs 18.6 crore in FY23, a 6% increase from FY22. This increase can be attributed to a 12.6% YoY growth in net profit in FY23. This is  0.3% of the company’s FY23 revenue of Rs 6,749.9 crore. 

    Shalabh Saxena, the Managing Director & CEO of Spandana Sphoorty Financial, comes in third, and draws an annual salary of Rs 15.7 crore in FY23, constituting 1.1% of the company’s FY23 revenue of Rs 1,477 crore. The CEO's salary rose to 15.6 crore from 15.7 lakh in FY22 due to the share based payment of Rs 15.1 crore made by the company in FY23.

    In the automobiles and auto components sector, Jayadev Galla, the Chairman, MD & CEO of Amara Raja Batteries, commands an annual remuneration of Rs 52.6 crore, marking a 38.5% increase from FY22. The rise in remuneration can be credited to a surge in net profit of 35.5% YoY for the company in FY23. His earnings make up 0.5% of the company’s FY23 revenue of Rs 10,480.2 crore. 

    Meanwhile, Rajiv Bajaj, the Managing Director & CEO of Bajaj Auto, gets an annual salary of Rs 47.6 crore in FY23, reflecting a modest 4.3% increase from FY22. This remuneration constitutes 0.1% of the company’s revenue of Rs 37,642.9 crore in FY23.

    Vivek Vikram Singh, Managing Director & Group CEO of Sona BLW Precision Forgings comes in third. He was paid Rs 12.5 crore as remuneration in FY23. His salary was reduced by 14.2% from FY22 due to a muted growth of 9% in the company’s net profit in FY23. 

    In the research & development heavy pharmaceutical and biotechnology sector, Kiran S Divi, the Whole-Time Director & CEO of the family-run Divi’s Laboratories, holds the highest annual remuneration of Rs 24.8 crore in FY23, despite experiencing a 34.2% reduction in pay from FY22. The company saw a fall in net profit of 38.4% YoY in FY23. His earnings represent 0.3% of the company’s revenue in FY23. Chava Satyanarayana, the Executive Director & CEO of Laurus Labs, follows with an annual salary of Rs 18.6 crore in FY23, followed by Umang Vohra, the Managing Director & Global CEO of Cipla, who earns Rs 17.5 crore.

    Lastly, we look at the cost-sensitive metals and mining sector, where TV Narendran, the Managing Director & CEO of Tata Steel, commands an annual remuneration of Rs 18.7 crore in FY23, marking a 4.3% decrease from FY22. This fall can be associated with a fall in net profit of 78.2% YoY in FY23 . 

    Sunil Duggal, the Whole-Time Director & CEO of Vedanta, receives an annual salary of Rs 14.6 crore. Although the company’s net profit fell by 43.8% YoY in FY23 his compensation increased by 33.8% in the same period. 

    Jayant Acharya, Joint Managing Director & CEO of JSW Steel comes in third. He was compensated with Rs 10.7 crore as remunerations in FY23. His salary surged by 137.1% from FY22 levels although the company's net profit fell by 80% in FY23.

    For more details on annual CEO salaries, you can check Trendlyne’s CEO Salary Dashboard.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener screener test
    29 Aug 2023

    screener test

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener High Checklist Score Stocks
    25 Aug 2023

    High Checklist Score Stocks

    Stocks with high positive checklist score and low negative checklist
    Copy LinkShare onShare on Share on Share on
     
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd